ON DEMAND: ADA 2022 — Australian context, international perspectives


Watch again as an expert panel of endocrinologists presents their selection of transformational clinical data from the American Diabetes Association’s 82nd Scientific Sessions and discusses the impacts for practice.

Hosted by Professor Jonathan Shaw
Deputy Director (Clinical and Population Health), Baker Heart & Diabetes Institute; Professor in the School of Life Sciences, La Trobe University; Professor in the School of Public Health and Preventive Medicine, Monash University.


PRESENTING PANEL
Dr Shoshana Sztal-Mazer. Clinical Endocrinologist, Alfred Health; Adjunct Research Fellow, School of Public Health and Preventive Medicine, Monash University, Melbourne.

Professor Andrew Boulton. Professor of Medicine, the University of Manchester; Consultant Physician, Manchester Royal Infirmary; Visiting Professor, The University of Miami, Florida; President, International Diabetes Federation.

Associate Professor Jane Holmes-Walker. Staff Specialist, Department of Diabetes and Endocrinology, Westmead Hospital; Clinical Associate Professor, Sydney Medical School.

Associate Professor Michael d’Emden. Director of Department of Endocrinology and Diabetes, Royal Brisbane and Women’s Hospital.

ADS

This event was created independently by the limbic in collaboration with the Australian Diabetes Society, the host and panel. All studies were selected by the panel and all views expressed are those of the host and panel only.

Already a member?

Login to keep reading.

OR
Email me a login link
logo

© 2022 the limbic